Horizon 2020 New research calls for ‘Health, demographic change & wellbeing’

Work Programme 2018-2020 and funding opportunities

The multi-annual work programme for 2018-2020 in Horizon 2020, the EU’s research funding instrument, has now been published. This is the final cycle of the Horizon 2020 programme. With the principle of research for better health for all at its core, Horizon 2020’s Societal Challenge 1 (SC1)  Health Demographic Change and Wellbeing focuses on personalised health and care. The new deadlines for submission start on April 18^th.  Although broadly focused in nature, the topics can be applied to research in kidney disease prevention and management. Such challenge-based (rather than disease-focused) approach, means that the fundamental criterion to obtain funding is scientific quality. The current Horizon 2020 programme (2014-2020) has already supported 22 projects specifically in kidney health with a cumulated contribution of EURO 47.6 million.

Work Program 2018-2020 work programme includes the following health themes:

• Personalised medicine
• Rare diseases
• Infectious diseases
• Non-communicable diseases
• Big data
• eHealth
• Integration of care

The New H2020 Calls are as follows, more information can be found on the links below:

• SC1-BHC-03-2018:  Exploiting research outcomes and application potential of the human microbiome for personalised prediction, prevention and treatment of disease 
• SC1-BHC-05-2018: International flagship collaboration with Canada for human data storage, integration and sharing to enable personalised medicine approaches
• SC1-BHC-09-2018: Innovation platforms for advanced therapies of the future
• SC1-BHC-15-2018: New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID)
• SC1-BHC-16-2018: Global Alliance for Chronic Diseases (GACD) – Scaling-up of evidence-based health interventions at population level for the prevention and management of hypertension and/or diabetes
• SC1-BHC-23-2018: Novel patient-centred approaches for survivorship, palliation and/or end-of-life care 
• SC1-BHC-26-2018: HTA research to support evidence-based healthcare 
• SC1-HCO-01-2018-2019-2020: Actions in support of the International Consortium for Personalised Medicine
• SC1-HCO-02-2018: Data integration and data-driven in-silico models for enabling personalised medicine – a European standardization framework
• SC1-HCO-09-2018: Building international efforts on population and patient cohorts
• SC1-HCO-11-2018: Strategic collaboration in health research and innovation between EU and China
• SC1-HCO-12-2018: Innovation in healthcare – a CSA towards using pre-commercial procurement and public procurement of innovative solutions in healthcare systems